ABOUT FIBRICHECK
Transforming the way cardiac care is delivered
At FibriCheck, we want to empower patients globally to manage their heart health efficiently and effectively. We aim to reduce the burden of cardiovascular diseases by transforming the way cardiac care is delivered, empowering patients and healthcare providers with the right tools and actionable data.
"With digital healthcare, we are paving the way for a healthier society."
Lars Grieten
CEO & Co-founder of FibriCheck
The FibriCheck Story
FibriCheck is regulated as a medical device and authorized for use in the EU (CE1639), US (FDA cleared), UK, Australia, Singapore and Hong Kong.
With FibriCheck, users are empowered to detect and monitor cardiac arrhythmias, including atrial fibrillation, wherever and whenever they want without the need for additional hardware.
Healthcare professionals can gain valuable insights from our reliable, AI-powered PPG measurement results. By facilitating informed clinical decision-making and timely interventions, we can help streamline the way cardiac care is delivered. FibriCheck seamlessly integrates with healthcare and telemedicine apps and platforms.
FibriCheck can be used throughout the entire patient lifecycle, from early detection and stroke prevention to the management of cardiac arrhythmias, such as atrial fibrillation (AF). On top of that, our software can also be used for symptom management such as palpitations, as symptoms can be logged with each measurement. These symptoms are combined with the results of the measurements in reports, which can easily be shared with physicians for further follow-up.
Helping people live a longer, healthier and happier live, that’s our every day mission.
